Daniel Ontaneda
Overview
Explore the profile of Daniel Ontaneda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
158
Citations
1721
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
McGinley M, Harvey T, Ontaneda D, Weathers A, Cobb B, Patel A
Neurol Clin Pract
. 2024 Nov;
15(1):e200407.
PMID: 39583033
Background And Objectives: To characterize outpatient telemedicine utilization for neurologic conditions and identify potential disparities. Methods: All outpatient visits conducted by neurology clinicians at an academic medical health care system...
12.
Chien C, Cruz E Silva V, Geiter E, Meier D, Zimmermann H, Bichuetti D, et al.
Radiology
. 2024 Nov;
313(2):e233099.
PMID: 39530897
Background Patients with neuromyelitis optica spectrum disorder (NMOSD) are often seropositive for antibodies against aquaporin-4 (AQP4). The importance of MRI monitoring in this disease requires evaluation. Purpose To profile MRI...
13.
Badihian S, Mueller H, Dasari V, Mahmood S, Thakore N, Ontaneda D, et al.
Can J Neurol Sci
. 2024 Oct;
:1-13.
PMID: 39463281
No abstract available.
14.
Harrison D, Sati P, Klawiter E, Narayanan S, Bagnato F, Beck E, et al.
Brain Commun
. 2024 Oct;
6(5):fcae359.
PMID: 39445084
The use of ultra-high-field 7-Tesla (7T) MRI in multiple sclerosis (MS) research has grown significantly over the past two decades. With recent regulatory approvals of 7T scanners for clinical use...
15.
De Nadai A, Zamora R, Finch A, Miller D, Ontaneda D, Gunzler D, et al.
Mult Scler
. 2024 Oct;
30(13):1642-1652.
PMID: 39420575
Background: While standard clinical assessments provide great value for people with multiple sclerosis (PwMS), they are limited in their ability to characterize patient perspectives and individual-level symptom heterogeneity. Objectives: To...
16.
Chen L, Ren Z, Clark K, Lou C, Liu F, Cao Q, et al.
J Neuroimaging
. 2024 Oct;
34(6):750-757.
PMID: 39410780
Background And Purpose: Paramagnetic rim lesions (PRLs) are an MRI biomarker of chronic inflammation in people with multiple sclerosis (MS). PRLs may aid in the diagnosis and prognosis of MS....
17.
Kalia L, Asis A, Arbour N, Bar-Or A, Bove R, Di Luca D, et al.
Nat Rev Neurol
. 2024 Oct;
20(12):724-737.
PMID: 39375563
The development of disease-modifying therapies (DMTs) for neurological disorders is an important goal in modern neurology, and the associated challenges are similar in many chronic neurological conditions. Major advances have...
18.
Manning A, Manning A, Letchuman V, Letchuman V, Martin M, Martin M, et al.
AJNR Am J Neuroradiol
. 2024 Sep;
46(3):620-626.
PMID: 39332906
Background And Purpose: The central vein sign (CVS) is a proposed diagnostic imaging biomarker for multiple sclerosis (MS). The proportion of white matter lesions exhibiting the CVS (CVS+) is higher...
19.
Amezcua L, Rotstein D, Shirani A, Ciccarelli O, Ontaneda D, Magyari M, et al.
Lancet Neurol
. 2024 Sep;
23(10):1050-1062.
PMID: 39304244
The differential diagnosis of suspected multiple sclerosis has been developed using data from North America, northern Europe, and Australasia, with a focus on White populations. People from minority ethnic and...
20.
Palmer K, Ontaneda D, Harvey T, Mearns E, Patel A, Win N, et al.
Mult Scler
. 2024 Sep;
30(10):1350-1362.
PMID: 39240089
Background: The impact of teleneurology on healthcare utilization (HCU) in MS is unknown. Objective: Evaluate the association between teleneurology and HCU. Methods: A retrospective longitudinal analysis of HCU among adult...